After having our SME Lider status renovated in 2022, OWLPHARMA was awarded the PME Excelência ’21 (SME Excelence) status by IAPMEI. This award acknowledges companies, amongst the SME Lider status companies, for their merit and contribution to the national economy.
A Owlpharma abriu 9 vagas para recrutamento. A informação encontra-se no documento anexado!
Later last week, the new Annex 1 “Manufacture of Sterile Medicinal Products” has been published and our team has scrutinized the new guidance and their main changes.
A Owlpharma terminou recentemente os projetos co-financiados pelo Centro2020, Portugal2020 e pela União Europeia.
On February 18th it was announced in the “Journal official de la République française” that as of March 1st it is legal to cultivate cannabis for medical purposes in France.
Our list of available audit reports and planned reports has been updated on our website!